Recession, strong dollar dent J&J profits
China Daily | Updated: 2009-07-16 08:06
Tylenol, a Johnson & Johnson product, on a shelf at a Morton Williams Supermarket in New York. Bloomberg News |
TRENTON, New Jersey: Healthcare products maker Johnson & Johnson on Tuesday (local time) said its second-quarter profit fell 3.5 percent, as the global recession, strong dollar and generic competition took their toll on sales, particularly for prescription drugs.
Photo